EFFICACIA DELL'IDROSSICLOROCHINA SOLFATO NELLA TERAPIA DEL LICHEN EROSIVO DEL CAVO ORALE

Translated title of the contribution: Efficacy of hydroxychloroquine sulphate in the treatment of erosive lichen planus of the oral cavity

G. Ghigliotti, R. De Marchi

Research output: Contribution to journalArticle

Abstract

The erosive lichen planus of the oral cavity is a chronic and difficult to treat disease. The efficacy of hydroxychloroquine sulphate was evaluated in 2 patients recalcitrant to topical therapy with bethametasone and cyclosporine. The drug, given at 400 mg/day for one month, followed by 200/day for three months, induced the marked improvement of the disease and healing of erosions after only 20 days from the beginning of the treatment. There were no side effects. Hydroxychloroquine sulphate may be considered among systemic drugs effective in the treatment of the erosive lichen planus of the oral cavity.

Original languageItalian
Pages (from-to)341-343
Number of pages3
JournalGiornale Italiano di Dermatologia e Venereologia
Volume130
Issue number5
Publication statusPublished - 1995

Fingerprint

Hydroxychloroquine
Lichen Planus
Mouth
Pharmaceutical Preparations
Cyclosporine
Therapeutics

ASJC Scopus subject areas

  • Dermatology

Cite this

EFFICACIA DELL'IDROSSICLOROCHINA SOLFATO NELLA TERAPIA DEL LICHEN EROSIVO DEL CAVO ORALE. / Ghigliotti, G.; De Marchi, R.

In: Giornale Italiano di Dermatologia e Venereologia, Vol. 130, No. 5, 1995, p. 341-343.

Research output: Contribution to journalArticle

@article{be86527ca6a043428f1e9ced7eec77a6,
title = "EFFICACIA DELL'IDROSSICLOROCHINA SOLFATO NELLA TERAPIA DEL LICHEN EROSIVO DEL CAVO ORALE",
abstract = "The erosive lichen planus of the oral cavity is a chronic and difficult to treat disease. The efficacy of hydroxychloroquine sulphate was evaluated in 2 patients recalcitrant to topical therapy with bethametasone and cyclosporine. The drug, given at 400 mg/day for one month, followed by 200/day for three months, induced the marked improvement of the disease and healing of erosions after only 20 days from the beginning of the treatment. There were no side effects. Hydroxychloroquine sulphate may be considered among systemic drugs effective in the treatment of the erosive lichen planus of the oral cavity.",
keywords = "erosive lichen, hydroxychloroquine sulphate, oral cavity",
author = "G. Ghigliotti and {De Marchi}, R.",
year = "1995",
language = "Italian",
volume = "130",
pages = "341--343",
journal = "Minerva dermatologica",
issn = "0392-0488",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "5",

}

TY - JOUR

T1 - EFFICACIA DELL'IDROSSICLOROCHINA SOLFATO NELLA TERAPIA DEL LICHEN EROSIVO DEL CAVO ORALE

AU - Ghigliotti, G.

AU - De Marchi, R.

PY - 1995

Y1 - 1995

N2 - The erosive lichen planus of the oral cavity is a chronic and difficult to treat disease. The efficacy of hydroxychloroquine sulphate was evaluated in 2 patients recalcitrant to topical therapy with bethametasone and cyclosporine. The drug, given at 400 mg/day for one month, followed by 200/day for three months, induced the marked improvement of the disease and healing of erosions after only 20 days from the beginning of the treatment. There were no side effects. Hydroxychloroquine sulphate may be considered among systemic drugs effective in the treatment of the erosive lichen planus of the oral cavity.

AB - The erosive lichen planus of the oral cavity is a chronic and difficult to treat disease. The efficacy of hydroxychloroquine sulphate was evaluated in 2 patients recalcitrant to topical therapy with bethametasone and cyclosporine. The drug, given at 400 mg/day for one month, followed by 200/day for three months, induced the marked improvement of the disease and healing of erosions after only 20 days from the beginning of the treatment. There were no side effects. Hydroxychloroquine sulphate may be considered among systemic drugs effective in the treatment of the erosive lichen planus of the oral cavity.

KW - erosive lichen

KW - hydroxychloroquine sulphate

KW - oral cavity

UR - http://www.scopus.com/inward/record.url?scp=0029617977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029617977&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:0029617977

VL - 130

SP - 341

EP - 343

JO - Minerva dermatologica

JF - Minerva dermatologica

SN - 0392-0488

IS - 5

ER -